JP2009503076A5 - - Google Patents

Download PDF

Info

Publication number
JP2009503076A5
JP2009503076A5 JP2008525054A JP2008525054A JP2009503076A5 JP 2009503076 A5 JP2009503076 A5 JP 2009503076A5 JP 2008525054 A JP2008525054 A JP 2008525054A JP 2008525054 A JP2008525054 A JP 2008525054A JP 2009503076 A5 JP2009503076 A5 JP 2009503076A5
Authority
JP
Japan
Prior art keywords
alkyl
phenyl
tetrahydro
pyrido
pyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008525054A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009503076A (ja
JP5066088B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/029437 external-priority patent/WO2007019083A1/en
Publication of JP2009503076A publication Critical patent/JP2009503076A/ja
Publication of JP2009503076A5 publication Critical patent/JP2009503076A5/ja
Application granted granted Critical
Publication of JP5066088B2 publication Critical patent/JP5066088B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008525054A 2005-08-04 2006-07-27 セロトニン受容体モジュレーターとしてのピリミジン化合物 Expired - Fee Related JP5066088B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70571905P 2005-08-04 2005-08-04
US60/705,719 2005-08-04
PCT/US2006/029437 WO2007019083A1 (en) 2005-08-04 2006-07-27 Pyrimidine compounds as serotonin receptor modulators

Publications (3)

Publication Number Publication Date
JP2009503076A JP2009503076A (ja) 2009-01-29
JP2009503076A5 true JP2009503076A5 (enExample) 2009-08-13
JP5066088B2 JP5066088B2 (ja) 2012-11-07

Family

ID=37400981

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008525054A Expired - Fee Related JP5066088B2 (ja) 2005-08-04 2006-07-27 セロトニン受容体モジュレーターとしてのピリミジン化合物

Country Status (16)

Country Link
EP (1) EP1928461B1 (enExample)
JP (1) JP5066088B2 (enExample)
KR (1) KR101353268B1 (enExample)
CN (1) CN101277700B (enExample)
AT (1) ATE539753T1 (enExample)
AU (1) AU2006278759B2 (enExample)
BR (1) BRPI0614397A2 (enExample)
CA (1) CA2617760C (enExample)
CR (1) CR9791A (enExample)
EA (1) EA014495B1 (enExample)
IL (2) IL189164A (enExample)
NO (1) NO340744B1 (enExample)
NZ (1) NZ565334A (enExample)
UA (1) UA95247C2 (enExample)
WO (1) WO2007019083A1 (enExample)
ZA (1) ZA200802010B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06003150A (es) 2003-09-17 2006-08-31 Johnson & Johnson Compuestos heterociclicos fusionados.
US7598255B2 (en) * 2005-08-04 2009-10-06 Janssen Pharmaceutica Nv Pyrimidine compounds as serotonin receptor modulators
PE20080145A1 (es) * 2006-03-21 2008-02-11 Janssen Pharmaceutica Nv Tetrahidro-pirimidoazepinas como moduladores de trpv1
KR20090121358A (ko) * 2007-03-23 2009-11-25 화이자 리미티드 5-ht2c 작용제로서 피리미도 [4,5-d] 아제핀 유도체
JP5562865B2 (ja) 2007-12-17 2014-07-30 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Trpv1のイミダゾロ−、オキサゾロ−、及びチアゾロピリミジン・モジュレーター
WO2011146089A1 (en) * 2010-05-21 2011-11-24 Abbott Laboratories Modulators of 5-ht receptors and methods of use thereof
ES2703168T3 (es) 2014-05-29 2019-03-07 Taiho Pharmaceutical Co Ltd Nuevo compuesto de tetrahidropiridopirimidina o sal del mismo
CN107365314B (zh) * 2016-05-11 2024-09-27 国药集团国瑞药业有限公司 一种吡唑类化合物、其晶型及其制备方法
ES3050660T3 (en) * 2016-11-15 2025-12-22 Univ Temple 3-(2-(4-phenylpiperazin-1-yl)ethyl)-2-oxa-8-azaspiro[4.5]decan-1-one derivatives and related compounds as 5-hydroxytryptamine receptor 7 (5-ht7) modulators for treating e.g. inflammatory bowel disease, circadian rhythm disorder or depression
JP7141130B2 (ja) 2017-05-31 2022-09-22 ケモセントリックス,インコーポレイティド C5a阻害剤としての6-5融合環
US10828285B2 (en) * 2017-12-22 2020-11-10 Chemocentryx, Inc. Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors
UA127357C2 (uk) 2018-04-18 2023-07-26 Констеллатіон Фармацеутікалс, Інк. Модулятори метилмодифікуючих ферментів, композиції та їх використання
EP3797108B1 (en) 2018-05-21 2022-07-20 Constellation Pharmaceuticals, Inc. Modulators of methyl modifying enzymes, compositions and uses thereof
KR102282569B1 (ko) * 2019-02-08 2021-07-29 (주)퓨쳐켐 새로운 18F-표지된 친디엔체와 테트라진 화합물과의 IeDDA 반응을 이용한 18F-표지 방법
MD4003532T2 (ro) 2019-07-24 2025-01-31 Constellation Pharmaceuticals Inc Forme cristaline de 7-clor-2-(4-(3-metoxiazetidin-1-il)ciclohexil)-2,4-dimetil-N-((6-metil-4-(metiltio)-2-oxo-1,2-dihidropiridin-3-il)metil)benzo[d][1,3]dioxol-5-carboxamidă
KR102483492B1 (ko) * 2019-09-02 2023-01-02 한양대학교 에리카산학협력단 2,5-이치환된 피리미딘 유도체 및 이를 포함하는 약학적 조성물
WO2021097117A2 (en) * 2019-11-13 2021-05-20 Temple University-Of The Commonwealth System Of Higher Education Novel functionalized lactones as modulators of the 5-hydroxytryptamine receptor 7 and their method of use
EP4313967B1 (en) 2021-03-29 2025-11-12 Gilead Sciences, Inc. Khk inhibitors
JP2025505163A (ja) * 2022-02-02 2025-02-21 ザ・カトリック・ユニヴェルシテイト・ルーバン Yap/taz-teadを阻害するためのテトラヒドロピリドピリミジン及び関連類似体

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3969355A (en) * 1974-11-01 1976-07-13 Morton-Norwich Products, Inc. 5-Aminoethyl-2,4-diphenylpyrimidine dihydrobromide
JPH03148265A (ja) * 1989-11-01 1991-06-25 Sumitomo Chem Co Ltd 5,7―ジフェニル―4,6―ジアザインダン誘導体、その製造法およびそれを有効成分とする除草剤
US5137890A (en) * 1990-02-14 1992-08-11 Ortho Pharmaceutical Corporation 4-phenyl tetrahydropyrido(4,3-d)pyrimidines
DE69533284T2 (de) * 1994-04-29 2005-07-21 Pfizer Inc. Neue cyclische und acyclische amide zur erhöhung der neurotransmitter ausschüttung
AU2980797A (en) * 1996-06-11 1998-01-07 Yoshitomi Pharmaceutical Industries, Ltd. Fused heterocyclic compounds and medicinal uses thereof
KR20020005653A (ko) * 1999-04-01 2002-01-17 실버스타인 아써 에이. 소르비톨 디하이드로게나제 저해제로서의 아미노피리미딘
DE60008550T2 (de) * 1999-09-09 2004-08-05 Kumiai Chemical Industry Co., Ltd. Pyrimidinderivate und herbizide welche diese enthalten
WO2001068585A1 (en) * 2000-03-14 2001-09-20 Fujisawa Pharmaceutical Co., Ltd. Novel amide compounds
DE10111842A1 (de) * 2001-03-13 2002-09-19 Boehringer Ingelheim Pharma Antithrombotische Carbonsäureamide, deren Herstellung und deren Verwendung als Arzneimittel
MXPA06003150A (es) * 2003-09-17 2006-08-31 Johnson & Johnson Compuestos heterociclicos fusionados.

Similar Documents

Publication Publication Date Title
JP2009503076A5 (enExample)
US7598255B2 (en) Pyrimidine compounds as serotonin receptor modulators
RU2431635C2 (ru) Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1
US20100016281A1 (en) Pyrimidine compounds as serotonin receptor modulators
KR101353268B1 (ko) 세로토닌 수용체 모듈레이터로서의 피리미딘 화합물
JP2020050682A (ja) ドライアイおよび他の目に関連する疾患を治療するためのヤヌスキナーゼ阻害剤
AU2010245250B2 (en) Use of PDE7 inhibitors for the treatment of movement disorders
CN101557826A (zh) 泌尿系统疾病的治疗药
JP2000038350A (ja) 糖尿病治療薬
TW201333012A (zh) 咪唑并吡咯啶酮化合物
AU2013230128A1 (en) Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use
ZA200603031B (en) Fused heterocyclic componds as serotonin receptor modulators
CZ20022222A3 (cs) Nové substituované pyrazolo [4,3-e] diazepiny, farmaceutické kompozice obsahující tyto diazepiny, jejich použití jako léčiva a způsoby jejich přípravy
TWI325322B (en) Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one; and 7-pyrimidiny-2,3-dihydroimidazo[1,2-a] pyrimidin-5(1h)one derivatives
KR20250048344A (ko) 만성 피로, 탈진 및/또는 운동 불내성과 연관된 질환의 치료 및 예방을 위한 포스포디에스테라제-7 억제 활성을 갖는 치료제의 용도
HK1118469B (en) Pyrimidine compounds as serotonin receptor modulators
CN101155787A (zh) (3,4-二氢-喹唑啉-2-基)-茚满-1-基-胺